Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MVA Brachyury TRICOM vaccine - Bavarian Nordic

Next Previous
X
Search
Drug Profile

MVA Brachyury TRICOM vaccine - Bavarian Nordic

Alternative Names: BN-Brachyury; Brachyury/TRICOM; MVA-BN-Brachyury vaccine; MVA-BN-Brachyury/ FPV-Brachyury; MVA-brachyury-TRICOM

Latest Information Update: 28 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bavarian Nordic
  • Developer Bavarian Nordic; National Cancer Institute (USA); University of Utah
  • Class Antineoplastics; Cancer vaccines; Immunotherapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Chordoma
  • New Molecular Entity No

Highest Development Phases

  • Phase II Chordoma
  • Phase I/II Solid tumours
  • No development reported Prostate cancer

Most Recent Events

  • 28 Nov 2022 No recent reports of development identified for phase-I development in Solid-tumours(Inoperable/Unresectable, Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (IV)
  • 25 Jul 2022 No development reported - Phase-II for Prostate cancer (Combination therapy, Neoadjuvant therapy) in USA (Intratumoural)
  • 25 Jan 2022 Bavarian Nordic completes the phase II trial for Chordoma (Late-stage disease, Second-line therapy or greater) in USA (SC) (NCT03595228)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top